Akcea Therapeutics to Hold Fourth Quarter and Full Year 2019 Financial Results Webcast

Akcea Therapeutics, Inc.,a majority-owned affiliate ofIonis Pharmaceuticals, Inc.(NASDAQ: IONS), is a biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious and rare diseases.